Fecal Pancreatic Elastase Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028
The Global Fecal Pancreatic Elastase Testing Market was valued at around US$ 13.6 Mn in 2021 and is anticipated to register at a CAGR of 7% during the forecast period 2022-2028.
The fecal pancreatic elastase test is a type of test that measures the amount of elastase in the stool. The demand for fecal pancreatic elastase testing is increasing worldwide due to the increasing prevalence of exocrine pancreatic insufficiency (EPI). Elastase measurement is important because it plays an important role in the digestive process by breaking down fat, protein, and carbohydrates after a meal. This test checks the level of pancreatic elastase to help determine if the pancreas is functioning properly.
Market Segments
By Product
- Fecal Pancreatic Elastase ELISA Kits
- Rapid Fecal Pancreatic Elastase Kits
By Indication
- Chronic Pancreatitis
- Type 1 Diabetes
- Cystic Fibrosis
Key Players
- Laboratory Corporation of America® Holdings
- DiaSorin
- ScheBo Biotech AG
- Immundiagnostik AG
- Invivo Healthcare
- DRG Instruments GMBH
- Verisana Laboratories
- BÜHLMANN Laboratories AG
- CerTest Biotec S.L.
- R-Biopharm AG
- American Laboratory Products Company, Ltd.
- Vitassay Healthcare, S.L.U.
Scope of the Report
The research study analyzes the global Fecal Pancreatic Elastase Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Fecal Pancreatic Elastase Testing Market Report
1. What was the Fecal Pancreatic Elastase Testing Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Fecal Pancreatic Elastase Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Fecal Pancreatic Elastase Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation